# ZW Data Action Technologies Inc.: financial statements, quarterly

CNET · Nasdaq · CIK 1376321 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cnet.md) · [Financials](/companies/cnet/financials.md) · [Filings](/companies/cnet/filings.md) · [Insiders](/companies/cnet/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cnet/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [9,181](/filings/0001171843-24-006453.md) | [5,268 d](/filings/0001171843-25-002214.md) | [3,531](/filings/0001171843-25-003343.md) | [6,420](/filings/0001171843-25-005426.md) | [3,239](/filings/0001171843-25-007330.md) | [2,249 d](/filings/0001171843-26-002058.md) | [1,652](/filings/0001171843-26-003454.md) | [548](/filings/0001171843-26-005526.md) | [1,717](/filings/0001171843-25-007330.md) | [697 d](/filings/0001171843-26-002058.md) | [383](/filings/0001171843-26-003454.md) | [652](/filings/0001171843-26-005526.md) |
| Cost of revenue | $k | [9,185](/filings/0001171843-24-006453.md) | [5,275 d](/filings/0001171843-25-002214.md) | [3,459](/filings/0001171843-25-003343.md) | [6,092](/filings/0001171843-25-005426.md) | [3,184](/filings/0001171843-25-007330.md) | [2,258 d](/filings/0001171843-26-002058.md) | [1,492](/filings/0001171843-26-003454.md) | [501](/filings/0001171843-26-005526.md) | [1,619](/filings/0001171843-25-007330.md) | [649 d](/filings/0001171843-26-002058.md) | [356](/filings/0001171843-26-003454.md) | [605](/filings/0001171843-26-005526.md) |
| Gross profit | $k | [(4.0)](/filings/0001171843-24-006453.md) | [(7.0) d](/filings/0001171843-25-002214.md) | [72.0](/filings/0001171843-25-003343.md) | [328](/filings/0001171843-25-005426.md) | [55.0](/filings/0001171843-25-007330.md) | [(9.0) d](/filings/0001171843-26-002058.md) | [160](/filings/0001171843-26-003454.md) | [47.0](/filings/0001171843-26-005526.md) | [98.0](/filings/0001171843-25-007330.md) | [48.0 d](/filings/0001171843-26-002058.md) | [27.0](/filings/0001171843-26-003454.md) | [47.0](/filings/0001171843-26-005526.md) |
| Research and development | $k | [0.0](/filings/0001171843-24-006453.md) | [(1.0) d](/filings/0001171843-25-002214.md) | [0.0](/filings/0001171843-24-004216.md) | [0.0](/filings/0001171843-24-004837.md) | [0.0](/filings/0001171843-24-006453.md) | [0.0 d](/filings/0001171843-26-002058.md) | not reported | [0.0](/filings/0001171843-26-005526.md) | not reported | not reported | not reported | [13.0](/filings/0001171843-26-005526.md) |
| Operating income | $k | [(1,606)](/filings/0001171843-24-006453.md) | [(1,758) d](/filings/0001171843-25-002214.md) | [(922)](/filings/0001171843-25-003343.md) | [(301)](/filings/0001171843-25-005426.md) | [(1,992)](/filings/0001171843-25-007330.md) | [(542) d](/filings/0001171843-26-002058.md) | [(579)](/filings/0001171843-26-003454.md) | [(682)](/filings/0001171843-26-005526.md) | [(153)](/filings/0001171843-25-007330.md) | [(539) d](/filings/0001171843-26-002058.md) | [79.0](/filings/0001171843-26-003454.md) | [(381)](/filings/0001171843-26-005526.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [2.0](/filings/0001171843-24-006453.md) | [(2.0) d](/filings/0001171843-25-002214.md) | [(3.0)](/filings/0001171843-25-003343.md) | [(1.0)](/filings/0001171843-25-005426.md) | [0.0](/filings/0001171843-25-007330.md) | [403 d](/filings/0001171843-26-002058.md) | [1.0](/filings/0001171843-26-003454.md) | [(1.0)](/filings/0001171843-26-005526.md) | [1.0](/filings/0001171843-25-007330.md) | [0.0 d](/filings/0001171843-26-002058.md) | [(3.0)](/filings/0001171843-26-003454.md) | [(4.0)](/filings/0001171843-26-005526.md) |
| Net income | $k | [(1,520)](/filings/0001171843-24-006453.md) | [(1,908) d](/filings/0001171843-25-002214.md) | [(850)](/filings/0001171843-25-003343.md) | [(216)](/filings/0001171843-25-005426.md) | [(1,914)](/filings/0001171843-25-007330.md) | [(781) d](/filings/0001171843-26-002058.md) | [(531)](/filings/0001171843-26-003454.md) | [(637)](/filings/0001171843-26-005526.md) | [(108)](/filings/0001171843-25-007330.md) | [(494) d](/filings/0001171843-26-002058.md) | [126](/filings/0001171843-26-003454.md) | [(350)](/filings/0001171843-26-005526.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [(0.84)](/filings/0001171843-24-006453.md) | not reported | [(0.44)](/filings/0001171843-25-003343.md) | [(0.11)](/filings/0001171843-25-005426.md) | [(1.06)](/filings/0001171843-25-007330.md) | not reported | [(0.23)](/filings/0001171843-26-003454.md) | [(0.27)](/filings/0001171843-26-005526.md) | [(0.04)](/filings/0001171843-25-007330.md) | not reported | [0.04](/filings/0001171843-26-003454.md) | [(0.10)](/filings/0001171843-26-005526.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.3](/filings/0001171843-23-007191.md) | [0.8](/filings/0001171843-25-002214.md) | [0.5](/filings/0001171843-24-004216.md) | [0.5](/filings/0001171843-24-004837.md) | [1.1](/filings/0001171843-24-006453.md) | [0.8](/filings/0001171843-26-002058.md) | [0.8](/filings/0001171843-25-003343.md) | [1.7](/filings/0001171843-25-005426.md) | [1.8](/filings/0001171843-25-007330.md) | [1.0](/filings/0001171843-26-005526.md) | [0.7](/filings/0001171843-26-003454.md) | [0.6](/filings/0001171843-26-005526.md) |
| Current assets | $m | [9.4](/filings/0001171843-23-007191.md) | [9.0](/filings/0001171843-25-002214.md) | [9.3](/filings/0001171843-24-004216.md) | [9.4](/filings/0001171843-24-004837.md) | [9.9](/filings/0001171843-24-006453.md) | [9.2](/filings/0001171843-26-002058.md) | [8.2](/filings/0001171843-25-003343.md) | [8.0](/filings/0001171843-25-005426.md) | [8.5](/filings/0001171843-25-007330.md) | [7.6](/filings/0001171843-26-005526.md) | [7.4](/filings/0001171843-26-003454.md) | [7.8](/filings/0001171843-26-005526.md) |
| Total assets | $m | [14.8](/filings/0001171843-24-006453.md) | [11.2](/filings/0001171843-25-007330.md) | [11.4](/filings/0001171843-25-003343.md) | [10.8](/filings/0001171843-25-005426.md) | [11.0](/filings/0001171843-25-007330.md) | [9.7](/filings/0001171843-26-005526.md) | [9.5](/filings/0001171843-26-003454.md) | [9.2](/filings/0001171843-26-005526.md) | [9.7](/filings/0001171843-25-007330.md) | [9.7](/filings/0001171843-26-005526.md) | [9.5](/filings/0001171843-26-003454.md) | [9.8](/filings/0001171843-26-005526.md) |
| Current liabilities | $m | [5.1](/filings/0001171843-23-007191.md) | [4.9](/filings/0001171843-25-002214.md) | [5.9](/filings/0001171843-24-004216.md) | [5.4](/filings/0001171843-24-004837.md) | [6.0](/filings/0001171843-24-006453.md) | [5.8](/filings/0001171843-26-002058.md) | [6.1](/filings/0001171843-25-003343.md) | [5.4](/filings/0001171843-25-005426.md) | [6.0](/filings/0001171843-25-007330.md) | [5.1](/filings/0001171843-26-005526.md) | [4.9](/filings/0001171843-26-003454.md) | [5.4](/filings/0001171843-26-005526.md) |
| Total liabilities | $m | [6.5](/filings/0001171843-23-007191.md) | [5.0](/filings/0001171843-25-002214.md) | [6.0](/filings/0001171843-24-004216.md) | [5.6](/filings/0001171843-24-004837.md) | [6.1](/filings/0001171843-24-006453.md) | [6.0](/filings/0001171843-26-002058.md) | [6.4](/filings/0001171843-25-003343.md) | [5.7](/filings/0001171843-25-005426.md) | [6.2](/filings/0001171843-25-007330.md) | [5.3](/filings/0001171843-26-005526.md) | [5.1](/filings/0001171843-26-003454.md) | [5.6](/filings/0001171843-26-005526.md) |
| Shareholders' equity | $m | [8.2](/filings/0001171843-23-007191.md) | [6.3](/filings/0001171843-25-002214.md) | [5.4](/filings/0001171843-24-004216.md) | [5.2](/filings/0001171843-24-004837.md) | [4.8](/filings/0001171843-24-006453.md) | [3.7](/filings/0001171843-26-002058.md) | [3.1](/filings/0001171843-25-003343.md) | [3.5](/filings/0001171843-25-005426.md) | [3.3](/filings/0001171843-25-007330.md) | [4.3](/filings/0001171843-26-005526.md) | [4.3](/filings/0001171843-26-003454.md) | [4.1](/filings/0001171843-26-005526.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(674) d](/filings/0001171843-24-006453.md) | [(476) d](/filings/0001171843-25-002214.md) | [(353)](/filings/0001171843-25-003343.md) | [(677) d](/filings/0001171843-25-005426.md) | [(198) d](/filings/0001171843-25-007330.md) | [(830) d](/filings/0001171843-26-002058.md) | [(984)](/filings/0001171843-26-003454.md) | [685 d](/filings/0001171843-26-005526.md) | [(482) d](/filings/0001171843-25-007330.md) | [(148) d](/filings/0001171843-26-002058.md) | [(292)](/filings/0001171843-26-003454.md) | [(108) d](/filings/0001171843-26-005526.md) |
| Capital expenditure | $k | [52.0 d](/filings/0001171843-24-006453.md) | [29.0 d](/filings/0001171843-25-002214.md) | not reported | not reported | [0.0 d](/filings/0001171843-25-007330.md) | [0.0 d](/filings/0001171843-26-002058.md) | [37.0](/filings/0001171843-26-003454.md) | [28.0 d](/filings/0001171843-26-005526.md) | [0.0 d](/filings/0001171843-25-007330.md) | [0.0 d](/filings/0001171843-26-002058.md) | [0.0](/filings/0001171843-26-003454.md) | [0.0 d](/filings/0001171843-26-005526.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2013 (2013-03-31) | Q2 FY2013 (2013-06-30) | Q3 FY2013 (2013-09-30) | Q1 FY2014 (2014-03-31) | Q2 FY2014 (2014-06-30) | Q3 FY2014 (2014-09-30) | Q1 FY2015 (2015-03-31) | Q2 FY2015 (2015-06-30) | Q3 FY2015 (2015-09-30) | Q1 FY2016 (2016-03-31) | Q2 FY2016 (2016-06-30) | Q3 FY2016 (2016-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.2](/filings/0001171843-14-003309.md) | [22.2](/filings/0001171843-14-004014.md) | [22.4](/filings/0001171843-14-005614.md) | [22.4](/filings/0001171843-15-002903.md) | [22.4](/filings/0001171843-15-004722.md) | [22.4](/filings/0001171843-15-006369.md) | [26.4](/filings/0001171843-16-010083.md) | [26.8](/filings/0001171843-16-011778.md) | [10.8](/filings/0001171843-16-013219.md) | [28.4](/filings/0001171843-16-010083.md) | [28.4](/filings/0001171843-16-011778.md) | [11.4](/filings/0001171843-16-013219.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,668,429 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001171843-26-005526.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.